Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Post-treatment Lyme disease symptoms score: Developing a new tool for research.

Turk SP, Lumbard K, Liepshutz K, Williams C, Hu L, Dardick K, Wormser GP, Norville J, Scavarda C, McKenna D, Follmann D, Marques A.

PLoS One. 2019 Nov 11;14(11):e0225012. doi: 10.1371/journal.pone.0225012. eCollection 2019.

2.

Measurement of Organ-Specific and Acute-Phase Blood Protein Levels in Early Lyme Disease.

Zhou Y, Qin S, Sun M, Tang L, Yan X, Kim TK, Caballero J, Glusman G, Brunkow ME, Soloski MJ, Rebman AW, Scavarda C, Cooper D, Omenn GS, Moritz RL, Wormser GP, Price ND, Aucott JN, Hood L.

J Proteome Res. 2019 Nov 1. doi: 10.1021/acs.jproteome.9b00569. [Epub ahead of print]

PMID:
31618575
3.

A 14-day course of amoxicillin is a highly effective treatment for adult patients in the United States with erythema migrans.

Wormser GP, Brady KC, Cho MS, Scavarda CA, McKenna D.

Diagn Microbiol Infect Dis. 2019 Sep;95(1):104-105. doi: 10.1016/j.diagmicrobio.2019.03.009. Epub 2019 Mar 25. No abstract available.

PMID:
31174996
4.

Co-infections in Persons with Early Lyme Disease, New York, USA.

Wormser GP, McKenna D, Scavarda C, Cooper D, El Khoury MY, Nowakowski J, Sudhindra P, Ladenheim A, Wang G, Karmen CL, Demarest V, Dupuis AP 2nd, Wong SJ.

Emerg Infect Dis. 2019 Apr;25(4):748-752. doi: 10.3201/eid2504.181509.

5.

Efficacy of a 14-day course of amoxicillin for patients with erythema migrans.

Wormser GP, Brady KC, Cho MS, Scavarda CA, McKenna D.

Diagn Microbiol Infect Dis. 2019 Jun;94(2):192-194. doi: 10.1016/j.diagmicrobio.2019.01.003. Epub 2019 Jan 10.

PMID:
30728096
6.

Evaluation of Prospectively Followed Adult Patients with Erythema Migrans Using the Beck Depression Inventory Second Edition.

Wormser GP, Park K, Madison C, Rozenberg J, McKenna D, Scavarda C, Karmen C, Dornbush R, Visintainer P.

Am J Med. 2019 Apr;132(4):519-524. doi: 10.1016/j.amjmed.2018.11.039. Epub 2018 Dec 16.

PMID:
30562495
7.

Outcome of facial palsy from Lyme disease in prospectively followed patients who had received corticosteroids.

Wormser GP, McKenna D, Scavarda C, Karmen C.

Diagn Microbiol Infect Dis. 2018 Aug;91(4):336-338. doi: 10.1016/j.diagmicrobio.2018.03.016. Epub 2018 Apr 4.

PMID:
29720355
8.

Assessment of Duration of Tick Feeding by the Scutal Index Reduces Need for Antibiotic Prophylaxis After Ixodes scapularis Tick Bites.

Falco RC, Daniels TJ, Vinci V, McKenna D, Scavarda C, Wormser GP.

Clin Infect Dis. 2018 Aug 1;67(4):614-616. doi: 10.1093/cid/ciy221.

PMID:
29579163
9.

Fatigue in patients with erythema migrans.

Wormser GP, Sudhindra P, Lopez E, Patel L, Rezai S, Brumbaugh AD, McKenna D, Scavarda C, Shapiro ED, Karmen CL, Visintainer P.

Diagn Microbiol Infect Dis. 2016 Nov;86(3):322-326. doi: 10.1016/j.diagmicrobio.2016.07.026. Epub 2016 Jul 27.

10.

Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease.

Weitzner E, McKenna D, Nowakowski J, Scavarda C, Dornbush R, Bittker S, Cooper D, Nadelman RB, Visintainer P, Schwartz I, Wormser GP.

Clin Infect Dis. 2015 Dec 15;61(12):1800-6. doi: 10.1093/cid/civ735. Epub 2015 Sep 18.

11.

Long-term assessment of health-related quality of life in patients with culture-confirmed early Lyme disease.

Wormser GP, Weitzner E, McKenna D, Nadelman RB, Scavarda C, Molla I, Dornbush R, Visintainer P, Nowakowski J.

Clin Infect Dis. 2015 Jul 15;61(2):244-7. doi: 10.1093/cid/civ277. Epub 2015 Apr 17.

PMID:
25888674
12.

Long-Term Assessment of Fibromyalgia in Patients with Culture-Confirmed Lyme Disease.

Wormser GP, Weitzner E, McKenna D, Nadelman RB, Scavarda C, Farber S, Prakash P, Ash J, Nowakowski J.

Arthritis Rheumatol. 2015 Mar;67(3):837-839. doi: 10.1002/art.38972. Epub 2014 Dec 2.

13.

Long-term assessment of fatigue in patients with culture-confirmed Lyme disease.

Wormser GP, Weitzner E, McKenna D, Nadelman RB, Scavarda C, Nowakowski J.

Am J Med. 2015 Feb;128(2):181-4. doi: 10.1016/j.amjmed.2014.09.022. Epub 2014 Oct 15.

PMID:
25447620

Supplemental Content

Loading ...
Support Center